Case report: Artesunate for severe acute Plasmodium falciparum infection in a patient with myasthenia gravis

American Journal of Tropical Medicine and Hygiene

Volumn 87, Issue 3, 2012, Pages 435-436

  Dournon, Nathalie ^a   Buffet, Pierre ^a,b,c   Caumes, Eric ^a   Clair, Bernard ^d   Jauréguiberry, Steṕhane ^a  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c INSTITUT PASTEUR   (France)

^d RAYMOND POINCARÉ HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTEMETHER PLUS BENFLUMETOL; ARTESUNATE; AZATHIOPRINE; PYRIDOSTIGMINE; ARTEMISININ DERIVATIVE;

ADULT; ARTICLE; BLOOD ANALYSIS; CASE REPORT; DISEASE SEVERITY; FEVER; HUMAN; MALARIA FALCIPARUM; MALE; MYASTHENIA GRAVIS; PTOSIS; TREATMENT OUTCOME; VOMITING; DRUG EFFECT; PARASITOLOGY; PATHOGENICITY; PLASMODIUM FALCIPARUM;

ARTESUNATE; PLASMODIUM FALCIPARUM;

ADULT; ARTEMISININS; HUMANS; MALARIA, FALCIPARUM; MALE; MYASTHENIA GRAVIS; PLASMODIUM FALCIPARUM; TREATMENT OUTCOME;

EID: 84865959863     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2012.12-0114     Document Type: Article

References (9)

1. Robberecht W, Bednarik J, Bourgeois P, van Hees J, Carton H, 1989. Myasthenic syndrome caused by direct effect of chloroquine on neuromuscular junction. Arch Neurol 46: 464-468. (Pubitemid 19099345)
2. Fischer PR, Walker E, 2002. Myasthenia and malaria medicines. J Travel Med 9: 267-268. (Pubitemid 35231004)
3. Vinetz JM, Cain J, Baunkeua V, Eastman RT, Fidock D, 2010. Chemotherapy of malaria. Brunton L, Chalmer B, Knollman B, eds. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 12th edition. New York: McGraw-Hill Professional, 1383-1418.
4. Bateman DN, Dyson EH, 1986. Quinine toxicity. Adverse Drug React Acute Poisoning Rev 5: 215-233. (Pubitemid 17010164)
5. Dondorp A, Nosten F, Stepniewska K, Day N, White N, 2005. Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial. Lancet 366: 717-725. (Pubitemid 41207233)
6. World Health Organization, 2010. WHO Guidelines for the Treatment of Malaria. 2nd edition. Geneva: World Health Organization.
7. Bedlack RS, Simel DL, Bosworth H, Samsa G, Tucker-Lipscomb B, Sanders DB, 1968-1970. Quantitative myasthenia gravis score: assessment of responsiveness and longitudinal validity. Neurology 64: 1968-1970.
8. Karbwang J, Tin T, Rimchala W, Sukontason K, Namsiripongpun V, Thanavibul A, Na-Bangchang K, Laothavorn P, Bunnag D, Harinasuta T, 1995. Comparison of artemether and quinine in the treatment of severe falciparum malaria in south-east Thailand. Trans R Soc Trop Med Hyg 89: 668-671. (Pubitemid 26016359)
9. Dondorp AM, Fanello CI, Hendriksen IC, Gomes E, Seni A, Chhaganlal KD, Bojang K, Olaosebikan R, Anunobi N, Maitland K, Kivaya E, Agbenyega T, Nguah SB, Evans J, Gesase S, Kahabuka C, Mtove G, Nadjm B, Deen J, Mwanga-Amumpaire J, Nansumba M, Karema C, Umulisa N, Uwimana A, Mokuolu OA, Adedoyin OT, Johnson WB, Tshefu AK, Onyamboko MA, Sakulthaew T, Ngum WP, Silamut K, Stepniewska K, Woodrow CJ, Bethell D, Wills B, Oneko M, Peto TE, von Seidlein L, Day NP, White NJ, 2010. Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomized trial. Lancet 376: 1647-1657.